Yahoo Web Search

Search results

1. • U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...

     The Woonsocket Call· 4 days ago

     (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the company' ...

2. • 

     ARCO Lisboa's Outlook Remains Sunny Despite the Gloomy Market

     Artnet News· 5 days ago

     The small fair, an offshoot of IFEMA Madrid’s well-established ARCO Madrid, may not yet be an...

3. • 

     No guarantee of federal aid for latest survivors in tornado-struck Western Kentucky

     Kentucky Lantern via Yahoo News· 3 days ago

     HOPKINS COUNTY — Raymond Emery has spent the past few nights leaning back in the front seat of his...

4. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 4 days ago

     U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational therapy would offer a new treatment option for patients with

5. • A Lesson From History: AI Is Not Likely To Kill Jobs

     Forbes· 23 hours ago

     AI adoption in businesses is beginning to grow. According to McKinsey’s State of AI in Early 2024 survey, which was released last week, nearly three quarters of U.S. businesses are now using ...

6. • 

     Little fish, big comeback: Endangered pupfish in Death Valley featured on television

     Las Vegas Sun· 22 hours ago

     The hosts of “Wild Kingdom: Protecting the Wild,” Rae Wynn-Grant and Peter Gros, bring collected...

7. • Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test

     GenomeWeb News· 7 days ago

     Extracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ...

8. • CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...

     Benzinga· 2 days ago

     EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival ...

9. • 

     After the Valley View tornado, it’s community over profits for local eateries

     Dallas Morning News· 3 days ago

     Only 15 minutes from where an EF2 tornado with speeds of 135 mph destroyed a Shell gas station and...

10. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

      Roanoke-Chowan News-Herald· 4 days ago

      MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive data from the ProstACT ...